147 related articles for article (PubMed ID: 31548894)
21. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.
Tikmani SS; Muhammad AA; Shafiq Y; Shah S; Kumar N; Ahmed I; Azam I; Pasha O; Zaidi AK
Clin Infect Dis; 2017 Jan; 64(2):184-189. PubMed ID: 27941119
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA
Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055
[TBL] [Abstract][Full Text] [Related]
24. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
[TBL] [Abstract][Full Text] [Related]
26. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial.
Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM;
J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506
[TBL] [Abstract][Full Text] [Related]
27. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
[TBL] [Abstract][Full Text] [Related]
28. Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial.
AFRIcan NEonatal Sepsis Trial Group
Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S33-8. PubMed ID: 23945574
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of prophylactic antibiotics in the management of children with kerosene-associated pneumonitis: a double-blind randomised controlled trial.
Balme KH; Zar H; Swift DK; Mann MD
Clin Toxicol (Phila); 2015; 53(8):789-96. PubMed ID: 26114347
[TBL] [Abstract][Full Text] [Related]
30. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082
[TBL] [Abstract][Full Text] [Related]
31. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
May S; Brown SP; Schmicker RH; Emerson SS; Nkwopara E; Ginsburg AS
Clin Trials; 2020 Apr; 17(2):129-137. PubMed ID: 31814441
[TBL] [Abstract][Full Text] [Related]
32. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
[TBL] [Abstract][Full Text] [Related]
33. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan.
Catchup Study Group
Arch Dis Child; 2002 Feb; 86(2):113-8. PubMed ID: 11827905
[TBL] [Abstract][Full Text] [Related]
35. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
37. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
[TBL] [Abstract][Full Text] [Related]
38. Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study.
King C; Colbourn T; Mankhambo L; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Mwansambo C; Nambiar B; Johnson ES; Platt RW; Mukanga D; McCollum ED
BMJ Open; 2016 Nov; 6(11):e011636. PubMed ID: 27852705
[TBL] [Abstract][Full Text] [Related]
39. Effect of enhancing audit and feedback on uptake of childhood pneumonia treatment policy in hospitals that are part of a clinical network: a cluster randomized trial.
Ayieko P; Irimu G; Ogero M; Mwaniki P; Malla L; Julius T; Chepkirui M; Mbevi G; Oliwa J; Agweyu A; Akech S; Were F; English M;
Implement Sci; 2019 Mar; 14(1):20. PubMed ID: 30832678
[TBL] [Abstract][Full Text] [Related]
40. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.
Agarwal G; Awasthi S; Kabra SK; Kaul A; Singhi S; Walter SD;
BMJ; 2004 Apr; 328(7443):791. PubMed ID: 15070633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
